Physician

Charles Lapeyre Thompson, M.D.

According to 2025 Medicare claims, Charles Thompson, M.D. (NPI: 1306006721) practices ophthalmology in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is EYE CLINIC A PROFESSIONAL MEDICAL CORP. (NPI: 1619915121; TIN: 720767582) and primary practice location at 70605-5362.

Thompson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,470 traditional Medicare patients, billed 4,109 HCPCS/CPT codes, and received $392,972 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 4,053 prescription claims across 751 beneficiaries totaling $294,752 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). 2023 DME data shows 11 claims. Open Payments data shows 10 records totaling $455. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $437,574 and ending at $392,972. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $130,278 to $294,752. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$288K$576K2015 Medicare payment: $437,574 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $544,989 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $528,547 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $576,245 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $559,412 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $314,918 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $481,475 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $437,708 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $447,482 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $392,972 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,4094,813$437,574
20161,7715,901$544,989
20171,8395,532$528,547
20181,9295,666$576,245
20191,9525,476$559,412
20201,4493,694$314,918
20211,6754,641$481,475
20221,6224,740$437,708
20231,6314,836$447,482
20241,4704,109$392,972

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$260K$521K2015 Drug cost: $130,278 (USD; Tot_Drug_Cst)2016 Drug cost: $166,237 (USD; Tot_Drug_Cst)2017 Drug cost: $259,942 (USD; Tot_Drug_Cst)2018 Drug cost: $277,790 (USD; Tot_Drug_Cst)2019 Drug cost: $385,137 (USD; Tot_Drug_Cst)2020 Drug cost: $371,103 (USD; Tot_Drug_Cst)2021 Drug cost: $520,708 (USD; Tot_Drug_Cst)2022 Drug cost: $429,320 (USD; Tot_Drug_Cst)2023 Drug cost: $470,349 (USD; Tot_Drug_Cst)2024 Drug cost: $294,752 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154261,500$130,278
20164511,638$166,237
20175822,590$259,942
20186662,952$277,790
20195962,787$385,137
20205262,775$371,103
20216573,167$520,708
20226823,361$429,320
20237363,783$470,349
20247514,053$294,752

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.6K$5.2K2015 Medicare payment: $4,157 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,396 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,212 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $5,171 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $1,480 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $620 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $753 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $555 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20159898$4,157
2016102102$4,396
20174646$2,212
20188383$5,171
20192525$1,480
20201212$620
20211414$753
2022N/RN/RN/R
20231111$555
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens201337$379
92014Established patient complete exam of visual system955965$75
92012Established patient problem focused exam of visual system430650$56
92083Exam of visual field with extended testing155260$25
92136Measurement of corneal curvature and depth of eye227601$16

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol1457,011$50,535
RestasisCyclosporine271,515$32,073
Prednisolone AcetatePrednisolone Acetate84432,911$28,583
LumiganBimatoprost452,660$22,244
IlevroNepafenac381,849$17,484

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$455Glaukos Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles Lapeyre Thompson, M.D.?

Tedicare shows public-source Medicare data for Charles Lapeyre Thompson, M.D. (NPI 1306006721), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Lapeyre Thompson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles Lapeyre Thompson, M.D.?

Charles Lapeyre Thompson, M.D. is linked to EYE CLINIC A PROFESSIONAL MEDICAL CORP. (billing NPI 1619915121) in the available physician profile data.

Does Charles Lapeyre Thompson, M.D. have Open Payments data?

Charles Lapeyre Thompson, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.